EGF and breast carcinoma: Heregulins are a group of EGF-like ligands for surface ERBB2, ERBB3 and ERBB4 which are often overexpressed in the breast cancers [5] and promote cell proliferation [6] and cell migration [7], in association with tumorigenesis and aggressive phenotypes [8].